Following international medical education in Switzerland and South Africa, Dr. Hundertmark started cardiology training in 2013. He finished his MD in 2014 which investigated a mutation in a transcriptional co-activator causing Dilated Cardiomyopathy in affected patients. During his clinical training he became site investigator for multiple clinical trials. In 2017, he decided to pursue his interest in clinical research and molecular imaging by enrolling for a Dphil (PhD) in Oxford (UK) which he finished in 2022. His latest interest is devoted to more intense clinical HF expertise which is why he is currently enrolled in the HFA’s 5th Postgraduate Course in Heart Failure